Patents by Inventor Hayley McKeen

Hayley McKeen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASSAY METHODS FOR THE DETERMINATION OF FKBPL EXPRESSION LEVEL IN THE CONTEXT OF BREAST CANCER
    Publication number: 20160169897
    Abstract: Disclosed are methods that employ FKBPL as a marker for a subject's sensitivity to endocrine therapies in the treatment of cancers, and as a predictive marker of cancer progression and disease free survival in relation to hormone responsive cancers.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 16, 2016
    Applicant: THE QUEEN'S UNIVERSITY OF BELFAST
    Inventors: Tracy ROBSON, David Hirst, Hayley McKeen, Christopher Byrne
  • Assay methods for the determination of FKBPL expression level in the context of breast cancer
    Patent number: 9110063
    Abstract: Disclosed are methods that employ FKBPL as a marker for a subject's sensitivity to endocrine therapies in the treatment of cancers, and as a predictive marker of cancer progression and disease free survival in relation to hormone responsive cancers.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: August 18, 2015
    Assignee: The Queen's University of Belfast
    Inventors: Tracy Robson, David Hirst, Hayley McKeen, Christopher Byrne
  • ASSAY METHODS FOR THE DETERMINATION OF FKBPL EXPRESSION LEVEL IN THE CONTEXT OF BREAST CANCER
    Publication number: 20120115830
    Abstract: Disclosed are methods that employ FKBPL as a marker for a subject's sensitivity to endocrine therapies in the treatment of cancers, and as a predictive marker of cancer progression and disease free survival in relation to hormone responsive cancers.
    Type: Application
    Filed: May 19, 2010
    Publication date: May 10, 2012
    Inventors: Tracy Robson, David Hirst, Hayley McKeen, Christopher Byrne